Open | - |
Close | - |
Volume / Avg. | 65.000 / 2.308M |
Day Range | - - - |
52 Wk Range | 0.801 - 9.620 |
Market Cap | $544.651M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 6.37% |
Days to Cover | 3.02 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mersana Therapeutics (NASDAQ: MRSN) through any online brokerage.
Other companies in Mersana Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Replimune Group (NASDAQ:REPL).
The latest price target for Mersana Therapeutics (NASDAQ: MRSN) was reported by JP Morgan on Tuesday, March 19, 2024. The analyst firm set a price target for 5.00 expecting MRSN to rise to within 12 months (a possible 11.36% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Mersana Therapeutics (NASDAQ: MRSN) is $4.49 last updated March 27, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Mersana Therapeutics.
Mersana Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Mersana Therapeutics.
Mersana Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.